🇺🇸 FDA
Patent

US 11007249

Compositions comprising pregnancy specific glycoproteins and methods of use thereof

granted A61KA61K38/1774A61P

Quick answer

US patent 11007249 (Compositions comprising pregnancy specific glycoproteins and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/1774, A61P, A61P37/06